Diving Into Diabetes

Fixed-ratio combinations of basal insulin and glucagon-like peptide-1 receptor agonist (GLP-1 RA) have demonstrated maintenance of HbA1c efficacy, less hypoglycemia, and weight loss compared to basal-bolus insulin therapies in previous trials, but what is the latest evidence comparing these strategies in those with type 2 diabetes? Our host, Dr. Ronald Goldenberg , takes a deeper look into this to...

With newer technologies being used to monitor blood glucose levels, how can we use data from continuous glucose monitoring (CGM) to inform the day-to-day management of diabetes? Our host, Dr. Ronald Goldenberg , takes a deeper look into this topic with Ms. Lori Berard, a Registered Nurse and Certified Diabetes Educator currently working as a Nurse Clinical Research Consultant in Winnipeg. She has...

Metrics beyond HbA1c such as glucose variability are emerging as key parameters that can help guide the daily management of diabetes, but what is the clinical relevance of such measures, particularly for those with diabetes taking basal insulin? Our host, Dr. Ronald Goldenberg , takes a deeper look into this topic with Dr. Tadej Battelino , Professor, Head, and Chair of Pediatrics at the Universit...

Continuous glucose monitoring (CGM) metrics are emerging as key parameters that can help guide the management of diabetes, but how can they be applied in clinical practice, particularly for those with diabetes taking basal insulin? Our host, Dr. Ronald Goldenberg, takes a deeper look into this topic with Dr. Tadej Battelino , Professor, Head, and Chair of Pediatrics at the University of Ljubljana...